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5 years of survival after complete resection and chemotherapy
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Case report
On her way to the supermarket, a 16-year-old teenager 
collapsed after a sudden stabbing abdominal pain radi-
ating to the back. She was referred to a local hospital 
unconscious and in cardiogenic shock. Echocardiogra-
phy revealed a large pericardial effusion; cardiac anat-
omy and function were normal. Pericardiocentesis 
yielded 100 ml of blood. With additional volume sup-
ply, vital parameters were stabilised. Aortic dissection 
was suspected and the patient was immediately trans-
ferred to our hospital for further treatment.
A thoracic and abdominal computed tomography (CT) 
scan did not show any aortic dissection and could not 
identify any other bleeding site. Because of the still on-
going haemorrhage via the pericardial drain an ex-
plorative midline sternotomy was performed, which 
revealed a 3 cm × 5 cm mass situated in the right atrium 
infiltrating the myocardium. Because of the unknown 
dignity, the tumour was partially resected and histo-
logical results were awaited before planning further 
best evidence-based treatment.
Histological workup of the frozen section showed a 
malignant mesenchymal tumour, and staining re-
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vealed an angiosarcoma (fig. 1). Whole body and cardiac 
magnetic resonance imaging (MRI) (fig. 2) and the anal-
ysis of peritoneal fluid taken during the first operation 
showed no evidence of a primary extracardiac tumour 
nor metastases. 
After interdisciplinary discussion, a further treatment 
strategy with curative intent was chosen. It consisted 
of a complete surgical tumour excision followed by 
chemotherapy. 
Cardiac surgery was performed 10 days after the first 
explorative sternotomy. The whole tumour infiltrating 
the right atrium could be resected in one piece while 
the patient was on cardiopulmonary bypass. The right 
atrial wall was reconstructed using a xenopericardial 
patch. Resection edges were histologically proven to be 
tumour free (R0). The patient remained in sinus 
rhythm and no arrhythmias occurred peri- or postop-
eratively. 
The resected tumour was characterised by a predomi-
nantly solid growth pattern with haemorrhagic areas 
and necrosis. It was composed of epitheloid and spin-
dle cells with marked atypia. The immunophenotype 
showed an angiomatous differentiation (positive stain-
ing for erythroblast transformation specific related 
gene [ERG]) corresponding to an angiosarcoma (figs 1a 
and 1b).
Postoperative recovery was uneventful. Chemo-
therapy following the Cooperative Weichteilsarkom 
Studiengruppe (CWG) Guidance 2009 “Rhabdomyosar-
coma-Like Tumours” was started 9 days after surgery 
and lasted for 5.5 months (cumulative doses: ifosfa-
mide: 54  g/m2, vincristine 10  mg/m2, doxorubicin: 
320 mg/m2, dactinomycin: 6.25 mg/m2). As a result of 
severe polyneuropathy of the lower extremities vin-
cristine was discontinued after five courses. 
Follow-up consisted of regular clinical visits combined 
with echocardiography, electrocardiogram (ECG), 24h-
ECG and cardiac MRI. The patient has remained asymp-
tomatic up to the present (5 years of follow-up). No ex-
aminations detected any sign of tumour recurrence or 
metastasis. The patient completed her education and 
works now as an office clerk. 
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Discussion
We present a rare case of a primary cardiac sarcoma 
successfully treated by a staged approach. Primary car-
diac malignancies are extremely rare, with an inci-
dence below 0.007 per 100 000 children, and sarcomas 
account for about 40% [1, 2]. In the literature, about 180 
cases (adults and children) with primary cardiac sarco-
mas have been described over the last four decades.
The initial presentation of this aggressive tumour is 
 often acute and at an already advanced stage [1, 5] with 
metastases present in 66–89% of the patients [1, 2]. Tu-
mour location in the right atrium is typical for cardiac 
sarcomas [3, 5]. 
In this case, the leading symptoms were related to a 
massive pericardial effusion. The tumour caused a cov-
ered perforation in the right atrial wall, but was not 
visible in the CT scan – a known difficulty because the 
tumour mass and the surrounding effusion or myocar-
dial mass may have similar densities. [7] Even MRI 
could barely depict the tumour (fig. 2). In our patient, 
the acute bleeding resulted in early detection of the 
 tumour, which was still small and without metastases. 
In terms of long-term survival, this might have been 
life-saving. 
The prognosis of sarcomas is usually very poor, with a 
median survival of only 1 month without surgery, and 
of up to 12 months with surgical resection [1, 6]. Aggres-
sive complete resection in combination with chemo-
therapy has a better prognosis [1, 3, 4, 8], as was the case 
for our patient. 
A proposed treatment strategy for this kind of tumour 
is to start chemotherapy before the surgical excision. 
The aims of this preoperative chemotherapy are to re-
duce the tumour mass and to treat possible metastasis, 
since prognosis depends on the following three fac-
tors: the presence of metastasis, the side of the tumour 
(a right-sided tumour being worse) and the ability to 
achieve an R0 resection [4].
Our patient had initially undergone emergency ster-
notomy to stop the life-threatening bleeding. Waiting 
for a first course of chemotherapy would have led to 
retrosternal adhesions, thus complicating further 
 cardiac surgery. Therefore we decided to perform com-
plete surgical excision first, and start chemotherapy 
after the total resection of the tumour. The fact that the 
tumour could be resected in toto may have improved 
the patient’s prognosis [4, 6, 8].
Neoadjuvant chemotherapy is an important strategy 
enabling a complete resection by reducing the tumour 
mass, but was not performed in our patient for the 
above-mentioned reasons. It is of note that the main-
stay of therapy is aggressive surgery, which has more 
influence on outcome than additional treatments such 
as chemotherapy and radiotherapy [1, 3, 4, 6, 8]. Radia-
tion can be used as an additional treatment option in 
selected cases, namely those with microscopic or mac-
roscopic residual disease after surgery [5, 8]. However, 
the suggested dose for radiation therapy for rhabdo-
myosarcoma-like tumours needs to be reduced and 
 adjusted to the cardiac location and to patient’s size.
Whether our patient additionally benefited from 
chemotherapy given according to a paediatric proto-
col, which was more aggressive than a usual adult pro-
tocol, remains unclear.
Figure 1: (a) Solid tumour with atypical epithelioid and spindle cells and (b) erythroblast 
transformation specific related gene (ERG) immunohistochemical staining showed 
 diffuse nuclear positivity. 
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In cases in which a R0 resection cannot be performed 
studies are controversial whether heart transplanta-
tion is a valuable treatment option [4]. For staging and 
follow up MRI and positron emission tomography 
(PET)-CT are recommended modalities. 
The course of our patient, who presented in an acute 
state, without metastases and with a successful R0 re-
section, is extremely rare [1]. The long, uneventful sur-
vival  of 5 years is extraordinary. Early diagnosis and 
aggressive resection are key points when facing a pa-
tient with cardiac sarcoma.
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Figure 2: Cardiac magnetic resonance (CMR) cine images (steady state free precession) in an axial (a) and in a short axis (b) 
view of the residual tumor after first resection. 
The mass (**) can be recognised on the back of the right atrial appendage, at the entrance of the superior vena cava. 
The  images also show presence of pericardial effusion (arrows).
LA: left atrium; RA: right atrium; RV: right ventricle; RVOT: right ventricular outflow tract; SVC: superior vena cava.
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